Entera Bio Overview
Entera Bio (ENTX) has a P/E ratio of -43.03, below the Healthcare sector average of 26.36.
Get informed when a big investor buys or sells
+ Follow-43.03
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Entera Bio (ENTX) currently reports a P/E ratio of -43.03. That is below the Healthcare sector average of 26.36. Use the charts on this page to explore Entera Bio's P/E ratio history and peer comparisons.
Entera Bio's P/E ratio of -43.03 is lower than the Healthcare sector average of 26.36. That is roughly 263.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Entera Bio's market price to a fundamental measure such as earnings, sales, or book value. At -43.03, ENTX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -43.03, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 26.36. From there, open related valuation or income-statement pages for Entera Bio, and consider following ENTX for alerts when major investors trade the stock.
Entera Bio is classified in the Healthcare sector. On P/E ratio, it currently shows -43.03 versus a sector average near 26.36. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENTX with unrelated industries.
